Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org comes to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tag: PCSK9 inhibitors

2 10/5/2018

What The New York Times didn’t say about a woman ‘caught in the crossfire’ between insurers and drugmakers

1 3/13/2018

Did a pricey cholesterol-lowering drug really reduce deaths, as headlines claim?

1 3/20/2017

No surprise: Repatha reality is messier than initial reports suggested

3 4/5/2016

Whiplash warning! Readers brace for possible neck injury as competing claims on statins hit the headlines

2 10/14/2015

Sponsored content, new cholesterol drugs, and the political process

2 6/10/2015

LDL – Lion King of Surrogate Endpoints – key cholesterol issue this week

7/22/2014

What the public doesn’t see about pharma trying to buy influence

11/7/2012

Pumping out heart news from the big Heart Association conference